VALU
$35.60-0.29 (-0.81%)
Value Line, Inc.
Recent News
Value Line's Q3 Earnings Rise Y/Y Driven by Investment Gains
VALU's Q3 EPS improve year over year on investment gains and EAM income, but declining publishing revenues and weaker assets under management highlight ongoing pressure on its core business.
Value Line: Fiscal Q3 Earnings Snapshot
NEW YORK (AP) — Value Line Inc. VALU) on Tuesday reported profit of $5.9 million in its fiscal third quarter. On a per-share basis, the New York-based company said it had net income of 63 cents.
The Zacks Analyst Blog JPMorgan, Johnson & Johnson, Applied Materials and Value Line
JPMorgan, Johnson & Johnson and Applied Materials stand out in new research reports, highlighting strong business momentum despite industry and macro headwinds.
Top Research Reports for JPMorgan, Johnson & Johnson & Applied Materials
JPMorgan targets 9% NII growth, Johnson and Johnson leans on new drugs and MedTech strength, and Applied Materials rides a semiconductor rebound despite rising risks.
Value Line (NASDAQ:VALU) shareholders have endured a 20% loss from investing in the stock three years ago
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...